Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Adalimumab MeSH Descriptor Data 2025


MeSH Heading
Adalimumab
Tree Number(s)
D12.776.124.486.485.114.224.060.250
D12.776.124.790.651.114.224.060.250
D12.776.377.715.548.114.224.200.250
Unique ID
D000068879
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000068879
Scope Note
A humanized monoclonal antibody that binds specifically to TNF-ALPHA and blocks its interaction with endogenous TNF RECEPTORS to modulate INFLAMMATION. It is used in the treatment of RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS; CROHN'S DISEASE and ULCERATIVE COLITIS.
Entry Term(s)
Adalimumab-adbm
Adalimumab-atto
Amjevita
Cyltezo
D2E7 Antibody
Humira
Pharm Action
Antirheumatic Agents
Tumor Necrosis Factor Inhibitors
Registry Numbers
FYS6T7F842
0
See Also
Tumor Necrosis Factor-alpha
Public MeSH Note
2016; ADALIMUMAB was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 2002-2015
History Note
2016 (2002)
Date Established
2016/01/01
Date of Entry
2015/07/01
Revision Date
2021/07/01
Adalimumab Preferred
Humira Narrower
Amjevita Narrower
Cyltezo Narrower
D2E7 Antibody Narrower
Adalimumab-atto Narrower
Adalimumab-adbm Narrower
page delivered in 0.15s